Acta Naturae
Scope & Guideline
Connecting Researchers through Groundbreaking Discoveries
Introduction
Aims and Scopes
- Molecular Biology and Genetics:
The journal publishes research on molecular mechanisms, genetic variations, and gene expression regulation, with a particular emphasis on novel genetic tools and methodologies. - Biotechnology and Bioengineering:
Research articles often explore innovative applications of biotechnology, including synthetic biology, recombinant DNA technology, and the development of therapeutic agents. - Cancer Research and Therapeutics:
A significant portion of the journal's content is dedicated to cancer biology, focusing on tumor microenvironments, signaling pathways, and potential therapeutic strategies. - Immunology and Infectious Diseases:
The journal covers topics related to immune responses, vaccine development, and the mechanisms of infectious diseases, particularly in the context of emerging viral pathogens. - Cell Biology and Physiology:
Research on cellular mechanisms, including autophagy, cell signaling, and the physiological role of cells in various contexts, is a core area of focus. - Nanotechnology in Medicine:
The journal features studies on the application of nanotechnology in biomedical research, including drug delivery systems and diagnostic tools. - Neuroscience and Neurobiology:
Acta Naturae includes research on neurological disorders, neuronal signaling, and the impact of genetic factors on brain function.
Trending and Emerging
- CRISPR and Genome Editing Technologies:
There's a growing interest in CRISPR and other genome editing technologies, reflecting their transformative potential in genetics and therapeutic applications. - Personalized Medicine and Genomics:
Emerging studies focus on personalized medicine approaches, particularly in cancer treatment and genetic disorders, emphasizing the need for tailored therapeutic strategies. - Nanomedicine and Drug Delivery Systems:
Research on nanotechnology applications in medicine, especially for targeted drug delivery and enhanced diagnostic techniques, is gaining momentum. - Synthetic Biology and Bioengineering:
The rise of synthetic biology as a field is evident, with increasing publications on engineered biological systems and their applications in biotechnology. - Neurobiology of Disease:
An increased focus on the molecular and cellular mechanisms underlying neurodegenerative diseases indicates a trend towards understanding the complexities of brain health. - Immunotherapy and Cancer Vaccines:
Research is increasingly directed towards innovative immunotherapeutic approaches, including cancer vaccines and monoclonal antibodies, reflecting advancements in cancer treatment.
Declining or Waning
- Classical Pharmacology:
There has been a noticeable decrease in studies focused solely on classical pharmacological approaches, with a shift towards more integrated and innovative methodologies in drug discovery. - Basic Virology Studies:
Research strictly limited to basic virology without a translational or therapeutic angle has become less frequent, as the interest shifts towards practical applications in vaccine and antiviral development. - Traditional Genetic Mapping Techniques:
The focus on classical genetic mapping techniques has diminished, likely due to the increasing prevalence of high-throughput sequencing technologies and advanced genetic editing tools. - In vitro Models of Disease:
While still relevant, there is a decline in the number of papers utilizing traditional in vitro models of disease, as more researchers favor complex in vivo systems and organ-on-chip technologies. - Environmental and Ecological Studies:
Research focusing on environmental impacts and ecological genetics has seen a decline, possibly overshadowed by the increasing emphasis on biomedical applications.
Similar Journals
FOLIA BIOLOGICA
Nurturing Scholarly Dialogue in Molecular BiologyFOLIA BIOLOGICA, published by Charles University Prague, First Faculty of Medicine, is an esteemed academic journal that has been contributing to the fields of Biochemistry, Cell Biology, Developmental Biology, Genetics, Immunology, and Molecular Biology since its inception in 1961. With an ISSN of 0015-5500, this journal serves as a vital platform for researchers and professionals to disseminate their findings and advance knowledge within these disciplines. Despite its current Category Quartiles ranking in the lower tiers (Q3 and Q4), FOLIA BIOLOGICA continues to provide valued insights and foster scholarly dialogue, particularly in its paralleled fields. The journal is headquartered in Prague, Czech Republic, and operates without Open Access options, which emphasizes its focus on curated, peer-reviewed content essential for academicians and students. By bridging theoretical and practical knowledge, FOLIA BIOLOGICA remains committed to enriching the scientific community and serving as a cornerstone for future research innovations.
Genes & Diseases
Bridging the gap between genetics and clinical applications.Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.
ACTA BIOCHIMICA POLONICA
Exploring the Frontiers of Biochemical KnowledgeACTA BIOCHIMICA POLONICA (ISSN: 0001-527X, E-ISSN: 1734-154X) is a distinguished journal published by the ACTA BIOCHIMICA POLONICA in Poland, with a rich history dating back to 1955. As a prominent platform for disseminating research, it currently holds a Category Quartile of Q3 in the fields of Biochemistry, Genetics, and Molecular Biology, reflecting its commitment to advancing knowledge in these critical areas. This journal is indexed in Scopus, ranking 124 out of 221, placing it in the 44th percentile among general biochemistry, genetics, and molecular biology journals. Although it does not operate under an open-access model, ACTA BIOCHIMICA POLONICA remains a vital resource for researchers, professionals, and students seeking to delve into the latest developments and discoveries in biochemistry and molecular biology. Its strategic focus on contemporary topics ensures that it plays an essential role in shaping future scientific inquiries and fostering collaboration across various disciplines.
Cell and Bioscience
Elevating the Standards of Cellular and Bioscience InquiryCell and Bioscience is a prestigious open-access journal published by BMC that has been at the forefront of biochemistry, genetics, and molecular biology since its inception in 2011. With an impressive impact factor, this journal has established itself as a vital resource for researchers and professionals in these rapidly advancing fields, reflecting its high ranking of #29 out of 221 in the Scopus classification and placing it in the 87th percentile. Based in the United Kingdom, Cell and Bioscience aims to foster innovation and dissemination of research findings addressing critical biological questions through rigorous peer-reviewed articles and inter-disciplinary approaches. The journal's open-access model ensures unrestricted access to transformative research, promoting collaboration and knowledge sharing among academics, students, and practitioners worldwide. With a commitment to maintaining excellence in the field, Cell and Bioscience provides an essential platform for those looking to contribute to the evolving landscape of biosciences.
EMBO JOURNAL
Advancing the frontiers of biochemistry and molecular biology.The EMBO JOURNAL, published by Wiley in Germany, is a renowned scientific journal that has been at the forefront of research in the fields of biochemistry, genetics, and molecular biology since its inception in 1982. With an impressive convergence of contributions leading up to 2024, this journal is recognized for its high impact, reflected in its Q1 rankings across multiple categories including Immunology, Molecular Biology, and Neuroscience. It holds a prestigious place in the academic community, standing out with an exemplary Scopus ranking of #3 in General Immunology and Microbiology and #6 in General Neuroscience, making it a critical resource for researchers, professionals, and students alike. The journal aims to publish transformative research that sheds light on the underlying mechanisms of biological processes, thus advancing our understanding of health and disease. While currently not offering open access, the EMBO JOURNAL continues to facilitate a rich exchange of knowledge through its rigorous peer-review process and commitment to excellence.
Life Science Alliance
Fostering Collaboration for a Healthier Tomorrow.Life Science Alliance, published by LIFE SCIENCE ALLIANCE LLC, is a premier open access journal that has been making significant contributions to the fields of Biochemistry, Genetics and Molecular Biology, Ecology, Health, Toxicology and Mutagenesis, and Plant Science since its inception in 2018. With an impressive ranking in Scopus, including Q1 quartile positions and high percentiles in relevant categories, this journal is a vital resource for researchers, professionals, and students alike who seek to advance knowledge and innovation in life sciences. The journal operates on an open access model, ensuring that research findings are freely available to the global scientific community, thereby enhancing the visibility and impact of published work. With a commitment to fostering collaboration and disseminating high-quality research, Life Science Alliance serves as an essential platform for the promotion and exchange of scientific knowledge, aiming to bridge gaps and stimulate discussions across multiple disciplines.
Cell Reports
Leading the Charge in Molecular Biology InsightsCell Reports is a prestigious open-access journal published by CELL PRESS that has firmly established itself as a leading voice in the fields of Biochemistry, Genetics, and Molecular Biology. Since its inception in 2012, the journal has provided an innovative platform for rapid dissemination of cutting-edge research, ensuring that high-quality findings are accessible to a global audience. With an impressive impact factor and ranking within the top 10% in its category, as reflected by its Q1 ranking in Scopus, Cell Reports serves a vital role in advancing scientific knowledge and fostering collaboration among researchers. The journal's commitment to the open-access model not only enhances visibility but also encourages the sharing of critical advancements in molecular biology. Situated in the Netherlands, its contributions are recognized worldwide, making Cell Reports an indispensable resource for scientists aiming to stay at the forefront of their fields and facilitate breakthroughs that may shape the future of biomedicine.
Frontiers in Bioscience-Landmark
Driving Impactful Research in the BiosciencesFrontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.
Cell Communication and Signaling
Unleashing Insights into Cell Communication DynamicsCell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.
Biochemistry and Biophysics Reports
Advancing the frontiers of life sciences research.Biochemistry and Biophysics Reports, published by Elsevier, serves as a vital platform for the dissemination of innovative research in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an Open Access model initiated in 2015, this journal aims to facilitate the unimpeded sharing of knowledge, allowing researchers, professionals, and students free access to significant findings and developments. The journal has established a presence in the academic community, currently holding a Q3 ranking in Biochemistry, Q2 in Biophysics, alongside its Q3 standings in both Cell Biology and Molecular Biology categories for 2023. These metrics underscore its commitment to quality and relevance, garnering attention with Scopus ranks reflecting its emerging influence. Located in the Netherlands, Biochemistry and Biophysics Reports continues to foster dialogue and collaboration among the scientific community through high-quality research outputs, contributing to advancements in understanding the intricate biochemical processes and biophysical principles that underpin life sciences.